Two Sigma Investments’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-18,617
Closed -$305K 4606
2021
Q2
$305K Sell
18,617
-32,973
-64% -$613K ﹤0.01% 3505
2021
Q1
$1.04M Sell
51,590
-4,182
-7% -$100K ﹤0.01% 2278
2020
Q4
$1.15M Buy
55,772
+13,064
+31% +$240K ﹤0.01% 1884
2020
Q3
$753K Buy
+42,708
New +$679K ﹤0.01% 1960
2020
Q2
Sell
-14,500
Closed -$141K 3414
2020
Q1
$141K Buy
+14,500
New +$188K ﹤0.01% 2763

Other funds holding PROF

Two Sigma Investments's PROF Position: Q3 2021 in Review

Two Sigma Investments sold out of Profound Medical (PROF) in Q3 2021, closing a stake of 18,617 shares — an estimated $305K sold.

Two Sigma Investments first reported a position in PROF in Q1 2020 and held it in 5 quarters. The position peaked at $1.15M in Q4 2020. 46 funds tracked by Wall St. Rank hold PROF as of Q3 2021.

  • Two Sigma Investments reported no remaining Profound Medical position as of Q3 2021 after selling out during the quarter.
  • Two Sigma Investments sold 18,617 Profound Medical shares in Q3 2021, an estimated $305K.
  • Two Sigma Investments first reported a position in Profound Medical in Q1 2020 and held it in 5 quarters.
  • Two Sigma Investments's Profound Medical position peaked at $1.15M in Q4 2020.
  • 46 funds tracked by Wall St. Rank held Profound Medical as of Q3 2021.

Based on Two Sigma Investments's 13F filing for Q3 2021, filed 15 Nov 2021.